Sunitinib-Induced Acute Liver Failure
We present a case of fatal acute liver failure and cardiomyopathy within 2 weeks of sunitinib therapy initiation for advanced pancreatic neuroendocrine carcinoma. We believe our case is unique due to the rarity of its presentation. It highlights hepatotoxicity as a potentially fatal side effect of sunitinib therapy.Case Rep Gastroenterol 2021;15:17 –21
Source: Case Reports in Gastroenterology - Category: Gastroenterology Source Type: research
More News: Brain | Cancer & Oncology | Carcinoma | Cardiology | Cardiomyopathy | Gastroenterology | Gastrointestinal Stromal Tumor (GIST) | Gleevec | Heart | Hepatocellular Carcinoma | Liver | Liver Cancer | Neurology | Pancreas | Pancreatic Cancer | Urology & Nephrology